HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hans-Henrik Parving Selected Research

irbesartan

11/2014Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
2/2014Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT).
8/2013Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin?
1/2010Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria.
10/2009Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.
10/2009Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.
1/2008Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.
12/2006Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy.
11/2006A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension.
9/2005Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hans-Henrik Parving Research Topics

Disease

73Diabetic Nephropathies (Diabetic Nephropathy)
10/2015 - 01/2002
45Albuminuria
10/2015 - 01/2002
28Chronic Kidney Failure (Chronic Renal Failure)
10/2015 - 07/2002
19Cardiovascular Diseases (Cardiovascular Disease)
12/2012 - 07/2002
18Hypertension (High Blood Pressure)
10/2013 - 01/2003
17Type 2 Diabetes Mellitus (MODY)
12/2011 - 10/2002
15Kidney Diseases (Kidney Disease)
03/2015 - 05/2004
10Proteinuria
03/2015 - 03/2004
10Stroke (Strokes)
11/2014 - 01/2003
10Inflammation
06/2013 - 05/2005
8Coronary Artery Disease (Coronary Atherosclerosis)
01/2015 - 11/2010
7Myocardial Infarction
11/2014 - 01/2003
7Anemia
11/2013 - 03/2005
5Heart Failure
11/2014 - 08/2004
4Body Weight (Weight, Body)
09/2015 - 01/2008
4Diabetic Retinopathy (Retinopathy, Diabetic)
07/2009 - 10/2004
3Hyperkalemia
12/2012 - 12/2005
3Insulin Resistance
01/2009 - 03/2004
2Weight Gain
09/2015 - 01/2009
2Renal Insufficiency (Renal Failure)
02/2014 - 12/2012
2Fibrosis (Cirrhosis)
09/2012 - 01/2010
2Vitamin D Deficiency
01/2012 - 05/2011
2Diabetes Mellitus
12/2011 - 06/2004
2Hyperglycemia
11/2011 - 01/2003
2Diabetes Complications
11/2011 - 03/2011
2Atherosclerosis
01/2011 - 03/2004
2Dizziness (Lightheadedness)
12/2005 - 01/2002
2Coronary Disease (Coronary Heart Disease)
03/2004 - 01/2003
1Edema
05/2014
1Hypotension (Low Blood Pressure)
12/2012

Drug/Important Bio-Agent (IBA)

28CreatinineIBA
10/2015 - 08/2002
22Losartan (Cozaar)FDA LinkGeneric
10/2015 - 07/2002
19Biological Markers (Surrogate Marker)IBA
09/2015 - 11/2004
14irbesartanFDA LinkGeneric
11/2014 - 06/2002
13Angiotensin IIIBA
11/2014 - 08/2002
11Angiotensin Receptors (Angiotensin II Receptor)IBA
04/2009 - 07/2002
10aliskirenFDA Link
03/2015 - 06/2008
9Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
03/2015 - 01/2002
8Hemoglobins (Hemoglobin)IBA
09/2015 - 06/2004
8Angiotensin Receptor AntagonistsIBA
03/2015 - 10/2002
8pro-brain natriuretic peptide (1-76)IBA
01/2015 - 11/2007
6CholesterolIBA
10/2015 - 08/2002
6darbepoetin alfa (Aranesp)FDA Link
12/2011 - 03/2005
6Edetic Acid (EDTA)FDA Link
04/2008 - 01/2002
6Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2007 - 04/2003
5Insulin (Novolin)FDA Link
11/2014 - 01/2008
5ReninIBA
10/2013 - 06/2008
5AngiotensinsIBA
09/2011 - 08/2004
5Metformin (Glucophage)FDA LinkGeneric
03/2011 - 01/2008
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2009 - 01/2003
5candesartanIBA
07/2009 - 01/2002
4Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
10/2015 - 06/2004
4Uric Acid (Urate)IBA
10/2015 - 07/2009
4CalciumIBA
01/2015 - 01/2011
4LDL CholesterolIBA
09/2012 - 03/2008
4Brain Natriuretic Peptide (Natrecor)FDA Link
11/2011 - 11/2007
4Advanced Glycosylation End ProductsIBA
02/2011 - 12/2006
4Connective Tissue Growth FactorIBA
01/2011 - 06/2005
3PotassiumIBA
10/2015 - 12/2005
3atrasentanIBA
09/2015 - 05/2014
3Spironolactone (Aldactone)FDA LinkGeneric
06/2013 - 09/2005
3AdiponectinIBA
01/2013 - 11/2006
3valsartan (Vals)FDA Link
01/2010 - 04/2003
3Hemoglobin AIBA
11/2009 - 11/2003
3Lisinopril (Prinivil)FDA LinkGeneric
09/2009 - 01/2002
3repaglinide (Prandin)FDA Link
01/2009 - 01/2008
2Complement System Proteins (Complement)IBA
10/2015 - 10/2014
2Endothelin A ReceptorIBA
09/2015 - 05/2014
2Calcitriol Receptors (Calcitriol Receptor)IBA
03/2015 - 11/2010
2Endothelins (Endothelin)IBA
03/2015 - 05/2014
2atorvastatin (Lipitor)FDA Link
03/2015 - 06/2009
2rosuvastatin (Crestor)FDA Link
03/2015 - 04/2009
2LipidsIBA
02/2015 - 03/2008
2AngiotensinogenIBA
08/2013 - 11/2003
2Serum Amyloid A Protein (Serum Amyloid A)IBA
06/2013 - 01/2013
2C-Reactive ProteinIBA
01/2013 - 10/2011
2Glucose (Dextrose)FDA LinkGeneric
11/2011 - 02/2008
2Troponin T (T, Troponin)IBA
11/2011 - 10/2011
2Fatty Acid-Binding ProteinsIBA
05/2011 - 09/2009
2LipocalinsIBA
05/2011 - 01/2011
2GelatinasesIBA
05/2011 - 01/2011
2Type 1 Angiotensin ReceptorIBA
05/2011 - 11/2003
2OsteoprotegerinIBA
01/2011 - 12/2010
2PeptidesIBA
01/2010 - 01/2008
2Antihypertensive Agents (Antihypertensives)IBA
11/2009 - 06/2004
2N,N-dimethylarginine (asymmetric dimethylarginine)IBA
04/2008 - 03/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2008 - 12/2006
2DiureticsIBA
09/2005 - 06/2002
2EnalaprilFDA LinkGeneric
08/2003 - 01/2002
1Insulin-Like Growth Factor Binding Protein 4IBA
08/2015
1ficolinIBA
10/2014
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2013
1Fibronectins (Fibronectin)IBA
01/2013
1Proteins (Proteins, Gene)IBA
01/2013
1ApolipoproteinsIBA
01/2013

Therapy/Procedure

3Transplantation (Transplant Recipients)
12/2012 - 09/2004
2Renal Replacement Therapy (Therapies, Renal Replacement)
12/2012 - 11/2011
2Protein-Restricted Diet (Diet, Protein Restricted)
01/2011 - 07/2002
2Amputation
01/2005 - 01/2003
1Resuscitation
12/2012